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Summary
Mycoplasma mycoides subsp. capri (Mmc) and
subsp. mycoides (Mmm) are important ruminant
pathogens worldwide causing diseases such as pleu-
ropneumonia, mastitis and septicaemia. They
express galactofuranose residues on their surface,
but their role in pathogenesis has not yet been deter-
mined. The M. mycoides genomes contain up to
several copies of the glf gene, which encodes an
enzyme catalysing the last step in the synthesis of
galactofuranose. We generated a deletion of the glf
gene in a strain of Mmc using genome transplantation
and tandem repeat endonuclease coupled cleavage
(TREC) with yeast as an intermediary host for the
genome editing. As expected, the resulting YCp1.1-
Δglf strain did not produce the galactofuranose-
containing glycans as shown by immunoblots and
immuno-electronmicroscopy employing a galacto-
furanose specific monoclonal antibody. The mutant
lacking galactofuranose exhibited a decreased
growth rate and a significantly enhanced adhesion to
small ruminant cells. The mutant was also ‘leaking’ as
revealed by a β-galactosidase-based assay employ-
ing a membrane impermeable substrate. These
findings indicate that galactofuranose-containing
polysaccharides conceal adhesins and are important
for membrane integrity. Unexpectedly, the mutant
strain showed increased serum resistance.
Introduction
Infectious diseases caused by members of the genus
Mycoplasma feature prominently on the list of bacterial
pneumonias in humans and in diverse livestock species.
Currently, disease control depends to a large extent on
the use of antimicrobials for treating human mycoplasma
infections, and on suboptimal vaccines and movement
restriction combined with ‘test and slaughter’ policies for
controlling ruminant diseases. The use of antimicrobials
bears the risk of generating resistant Mycoplasma spp.,
as recently observed in China (Zhao et al., 2013) as well
as promoting the development of other resistant bacte-
ria. Various empirical approaches have been followed to
develop vaccines for infectious diseases caused by
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Mycoplasma spp., but the current lack of effective vac-
cines shows the limitations of such approaches that can
potentially be overcome by rationally designed novel
vaccines (Rueckert and Guzman, 2012; Jores et al.,
2013).
Contagious bovine pleuropneumonia (CBPP) caused
by M. mycoides subsp. mycoides (Mmm), a recently
evolved pathogen (Dupuy et al., 2012; Fischer et al.,
2012), is a major livestock disease in Africa that is cur-
rently spreading and affects most countries in sub-
Saharan Africa. This spread can be attributed to factors
such as financial constraints, poor veterinary services
and the difficulties of disease control in traditional pas-
toralist systems and cannot be prevented by the current
live vaccine that confers limited immunity, which lasts for
only up to 1 year (Thiaucourt et al., 2000; Jores et al.,
2013).
The development of an efficient vaccine has been ham-
pered by a lack of understanding of host–pathogen inter-
actions during disease. Until recently, the mutagenesis
techniques available for M. mycoides such as transposon
mutagenesis were inefficient, and the results were
ambiguous. Transposon insertions can affect expression
of neighbouring genes through homology-based silencing
and/or read-through activity of regulatory elements
(Rebollo et al., 2012). Moreover, transposons quite often
have integration site preferences. The lack of suitable
genetic tools to perform site-directed mutagenesis in
many Mycoplasma species has hampered our current
understanding of their biology and interactions with their
hosts. However, with the recent advent of synthetic
genomics, M. mycoides subsp. capri (Mmc), the closest
relative of Mmm, has become a model organism for
studies on whole genome synthesis (Gibson et al., 2010),
genome transplantation (Lartigue et al., 2007) and
genome editing using tandem repeat endonuclease
coupled cleavage (TREC) (Noskov et al., 2010), which
exploit yeast as an intermediary host for the mycoplasma
genome (Lartigue et al., 2009). These new techniques
now open up to a new era in mycoplasma research,
where site-directed mutagenesis can be performed in a
systematic and efficient manner to understand the biology
and pathogenesis of the bacteria.
Carbohydrate capsules were first reported for
M. mycoides about 50 years ago (Buttery and Plackett,
1960; Plackett and Buttery, 1964). Since then, studies have
shown that the carbohydrates can either be secreted
(EPS) or constitute a capsule (CPS). Both the CPS
and EPS produced by Mmm consist of a β-(1→6)-
galactofuranose homopolymer (Bertin et al., 2013; 2015),
referred to as galactan in this study. Previous studies
indicated that CPS in Mycoplasma spp. contributes to
adhesion to epithelium (Tajima et al., 1982), has a down-
regulating effect on alveolar macrophages (Almeida et al.,
1992) and protects against complement (Bolland et al.,
2012; Gaurivaud et al., 2014), but the biological role in
pathogenicity in the ‘Mycoplasma mycoides cluster’
(Cottew et al., 1987) has not been clarified. It is widely
accepted that glycans, except zwitterionic carbohydrates,
are unable to induce a CD4+ T cell memory immune
response (Comstock and Kasper, 2006), which could
explain the lack of long-lasting immune responses after
vaccination with the existing live vaccines. It is important to
obtain more information on the role of carbohydrates with
respect to host–pathogen interactions, before a glycocon-
jugate vaccine research pathway for M. mycoides should
be followed. Therefore, attenuated strains represent prom-
ising tools that enable us to gauge the role of carbohy-
drates in pathogenicity.
Here we report the seamless deletion of the UDP-
galactopyranose mutase encoding gene (glf) in Mmc, a
model organism for its closest relative Mmm. We applied
genome editing of the Mmc genome YCpMmyc1.1 (YCp-
marked genome of the virulent strain GM12) in a yeast
host using the TREC system (Noskov et al., 2010) to
seamlessly delete glf before ‘backtransplanting’ the
genome into Mycoplasma capricolum devoid of restriction
enzyme (Lartigue et al., 2009). We then comparatively
evaluated the GM12 wild type and YCpMmyc1.1-Δglf
strains for membrane integrity, adhesion to primary cells,
growth rate and serum resistance.
Results
In silico identification of gene clusters harbouring glf in
members of the ‘Mycoplasma mycoides cluster’
The biosynthesis of UDP-α-D-galactofuranose involves
the enzymes UTP-glucose-1-phosphate uridylyl-
transferase, UDP-glucose 4-epimerase and UDP-
galactopyranose mutase (encoded by galU, galE and glf,
respectively) as depicted in Fig. 1A and Fig. S1. Glycosyl-
transferases use UDP-α-D-galactofuranose as the source
of galactofuranose residues in the biosynthesis of the
capsular polysaccharide (Richards and Lowary, 2009).
However, it is unknown which of the several in silico-
identified glycosyltransferases in M. mycoides is responsi-
ble for polymerisation.
A cluster of genes with a total size of about 10 kb
consisting of galU, galE, a glycosyltransferase encoding
gene epsG and glf was identified in Mmc strains GM12
and 95010 (Fig. 1B). The arrangement of these genes in
Mmc strains GM12 and 95010 differed only with respect
to the insertion site of an IS-element (Fig. 1B). In Mmm
PG1 and Gladysdale, the entire cluster has a size of
approximately 30 kb due to a tandem repeat of the gene
cluster and the inclusion of another glycosyltransferase
encoding gene cps (Fig. 1B). Although the annotation of
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the genomes of Mmm PG1 and Gladysdale reveals the
presence of three copies of the gene glf, two of them
have a single nucleotide deletion leading to a frameshift
resulting in premature stop codons and truncated
reading frames of 927 bp instead of full-length 1,188 bp.
Because the major component of both the capsule
and excreted polysaccharides in Mmm and Mmc has
been shown to be galactofuranose (Plackett and Buttery,
1964; Bertin et al., 2013; 2015), we focused our work
on UDP-galactopyranose mutase encoded by glf,
which converts UDP-α-D-galactopyranose into UDP-α-
D-galactofuranose. Extensive searches for glf in other
species of the ‘Mycoplasma mycoides cluster’ did not
reveal the presence of this gene in the genomes of
M. capricolum subsp. capricolum (Mcc), M. capricolum
subsp. capripneumniae (Mccp) or M. leachii.
B
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Fig. 1. M. mycoides subsp. mycoides and M. mycoides subsp. capri harbour either three copies (one full length functional and two truncated
non-functional) or one copy (functional) of the UDP-galactopyranose mutase encoding gene glf respectively.
(A) Cartoon based on a KEGG analysis displaying the biosynthesis of UDP-α-D-galactofuranose starting from D-glucose-1-phosphate. (B)
Cartoon representing the gene clusters harbouring the UDP galactopyranose mutase encoding glf in the two ‘M. mycoides cluster’ members
M. mycoides subsp. mycoides (strains Gladysdale and PG1) and M. mycoides subsp. capri (strains GM12 and 95010). Other genes within the
locus are galU encoding UTP-glucose-1-phosphate uridylyltransferase, epsG encoding a glycosyltransferase and galE encoding UDP-glucose
4-epimerase). In Mmm, the locus also contains the cps encoding a glycosyltransferase.
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Functional testing of Mmc and Mmm
UDP-galactopyranose mutases using an E. coli-based
complementation assay
Escherichia coli strains of the serotype O16 contain a
terminal galactofuranose residue linked to rhamnose in
their O antigen repeating units. The laboratory strain
W3110 is a derivative of O16 with a mutation in the wbbL
gene, involved in the addition of the second sugar, rham-
nose, to the O antigen subunit (Stevenson et al., 1994).
E. coli strain MFF1 (wbbL- glf-) is a derivative of W3110
that lacks both a functional wbbL and a glf gene (Feldman
et al., 1999). When complemented with the rhamnosyl
transferase WbbL, MFF1 produces an incomplete O
antigen subunit that lacks the terminal galactofuranose
residue. If this strain is complemented with both, wbbL
and a functional UDP-galactopyranose mutase (glf)
homologue, synthesis of full-length O antigen is restored
and the LPS carries a full O 16 antigen (Poulin et al.,
2010).
To test if glf homologues from Mmc and Mmm encode a
functional UDP-galactopyranose mutase, strain MFF1
was complemented with WbbL and plasmids containing
one of the glf genes (full-length or truncated from Mmm
Gladysdale and Mmc GM12). LPS preparations were
analysed by SDS-PAGE followed by silver staining
(Fig. 2). When MFF1 was complemented with WbbL, a
single incomplete O antigen subunit is transferred to lipid
A (lane 2). Introduction of full-length glf genes from Mmm
(lane 3) and Mmc (lane 4) into MFF1 WbbL+ resulted in
the production of fully polymerized O antigen. The trun-
cated glf gene from Mmm (lane 5) was unable to restore
O antigen synthesis. These results showed that Mmc and
Mmm contain functional glf genes, together with truncated
non-functional glf homologues in Mmm strains.
Presence of galactofuranose-containing galactan in
Mycoplasma mycoides strains
To confirm the presence of galactofuranose-containing
galactan in M. mycoides strains, we required specific anti-
bodies for galactan made of β-(1→6)-galactofuranose.
Among individual hybridoma cells screened by ELISA
technique, hybridoma AMMY10 produced an IgM anti-
body that bound both to whole Mmm Afadé and purified
Mmm Afadé capsular polysaccharide. A high molecular
weight pattern, typical of large polysaccharides, was
shown in a western blot using the AMMY10 monoclonal
antibody, similar to the pattern stained by the carbohy-
drate specific periodic acid-Schiff stain (PAS). The
isolated carbohydrates were free of proteins as shown
by Coomassie staining and by dot blot analysis using a
rabbit polyclonal antibody raised against full-length
recombinant Mmm elongation factor Tu. As both Mmm
and Mmc produce the same galactan, a β-(1→6)-
galactofuranose homopolymer (Bertin et al., 2013;
2015), and AMMY10 recognised purified carbohydrates
from Mmm and Mmc, we concluded that this monoclonal
antibody was specific for galactan consisting of β-(1→6)-
galactofuranose and proposed to use it in subsequent
analyses.
Expression of the galactofuranose-containing polysac-
charide was monitored by dot blot analysis of whole cell
lysates from 14 Mmm and 15 Mmc strains using the
monoclonal antibody AMMY10 (Fig. S2). As expected,
all Mmm strains reacted with the antibody. The M. capri-
colum subsp. capricolum control strain ATCC 27343 was
not recognised, which is in alignment with the absence
of the gene glf in this strain. Out of the 15 Mmc strains
tested, 13 reacted with the antibody. Only the two
Mmc strains PG3 and CapriL did not react with the mAb.
A recent study has also shown that Mmc PG3
and CapriL do not contain galactofuranose-containing
galactan (Bertin et al., 2015). Therefore, this analysis
additionally confirms the specificity of the monoclonal
antibody AMMY10 to recognise galactofuranose-
containing galactan.
Generation of a Mmc glf knock-out mutant
After transformation of Saccharomyces cerevisiae con-
taining the YCpMmyc1.1 genome with TREC (tandem
1 2 3 4 5
Core
Incomplete O-antigen
LPS
Fig. 2. Results of the in vivo complementation assays in
Escherichia coli to verify functionality of the glf encoded enzymes.
E. coli strain MFF1 (wbbL- glf-) produces complete LPS in its O
antigen repeating units only when complemented with wbbL and a
functional UDP-galactopyranose mutase (glf) homologue. LPS
preparations were analysed by SDS-PAGE followed by silver
staining of LPS. Lane 1, MFF1 E. coli strain alone, no O-antigen is
produced. Lane 2, MFF1 E. coli strain complemented with wbbL
and empty pEXT20 vector, only incomplete O-antigen is produced.
Lane 3, MFF1 E. coli strain complemented with wbbL and the
pEXT20 vector containing glf from Mmm strain Gladysdale
(MMS_A1075 spanning 1,188 bp), complete LPS is produced. Lane
4, MFF1 E. coli strain complemented with wbbL and the pEXT20
vector containing glf from Mmc strain GM12 (MMCAP1_0814
spanning 1,188 bp), complete LPS in produced. Lane 5, MFF1
E. coli strain complemented with wbbL and the pEXT20 vector
containing glf from Mmm strain Gladysdale (MMS_A1062 spanning
927 bp), only incomplete O-antigen is produced.
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repeat coupled with endonuclease cleavage) constructs
specific for deletion of the glf gene, integration of the
construct at the correct locus was confirmed via PCR. The
TREC construct was removed using counter selection,
and a seamless deletion of glf was confirmed by sequenc-
ing. As a result of the primer design for deletion of the
gene, the deletion extended from nucleotide 18 of the glf
gene to 15 nucleotides downstream of the glf stop codon.
The genome integrity after deletion was first confirmed via
a multiplex PCR employing eight primer pairs evenly
spread out over the Mmc genome. Amplicons of the
expected size from all primer pairs confirmed that the
genome had not undergone major recombination events
during propagation in yeast cells (Fig. S3A). Additionally,
the double band profile (∼670 kb and ∼420 kb) visible on
pulsed-field gel electrophoresis (PFGE) confirmed the
completeness of the YCpMmyc1.1-Δglf genome in two
yeast clones (Fig. S3B).
The entire genome with the deletion of the glf gene,
YCpMmyc1.1-Δglf, was then transplanted into recipient
cells Mcc RE(-). The integrity of the transplanted genome
in the resulting Mmc clone was confirmed using the mul-
tiplex PCR described above, and the seamless deletion of
glf was again confirmed using PCR (Fig. S4).
Full genome sequencing of the transplanted
YCpMmyc1.1-Δglf
To ensure the genome had not undergone any rearrange-
ments during the maintenance of the genome in yeast, we
sequenced the whole genome using PacBio technology.
De novo assembly and polishing resulted in one
single contig of 1 085 764 bp (GenBank Accession No.
CP012387). Mapping the genomic sequence to that of a
previously sequenced mutant GM12 clone, YCpMmyc1.1-
ΔtypeIIIres (GenBank Accession no. CP001668) (Lartigue
et al., 2009) revealed two expected rearrangements: the
deletion of the glf gene in YCpMmyc1.1-Δglf, and the
deletion of the gene encoding a type III restriction enzyme
in the reference genome. Three additional changes were
identified in YCpMmyc1.1-Δglf, which we confirmed by
Sanger sequencing. These were (i) A deletion of TATA
in a stretch of 12 TA repeats in an intergenic region
between two putative lipoproteins (MMCAP2_0900
and MMCAP2_0901); (ii) A SNP (C to T transition) in
MMCAP2_0183 encoding a putative maltose ABC trans-
porter permease, resulting in an amino acid change from
threonine to isoleucine at amino acid position 837 (out of
846); (iii) A deletion of an A nucleotide in a stretch of six As
at the 3′ end of galE (MMCAP2_0813), the gene located
upstream of glf. The encoded enzyme UDP-glucose-4-
epimerase forms part of the same pathway as UDP-
galactopyranose mutase (encoded by glf) (Fig. 1). This
single nucleotide deletion lead to a frameshift where the
two most C-terminal amino acids (Asn-Lys) of the wild-type
UDP-glucose 4-epimerase are replaced by a stretch of 27
amino acids before a stop codon.
Functional testing of the mutated
UDP-glucose-4-epimerase using an E. coli-based
complementation assay
Our sequencing data demonstrated that in the trans-
planted YCpMmyc1.1-Δglf, an undesired mutation in the
galE gene affecting the stop codon resulted in a protein
containing a C-terminal extension of 27 amino acids.
Since UDP-α-D-galactopyranose is required as a precur-
sor for the synthesis of UDP-α-D-galactofuranose by
UDP-galactopyranose mutase (Fig. 1), we explored if the
C-terminal extension affected UDP-glucose-4-epimerase
activity. Because UDP-α-D-galactose is also required for
the synthesis of O7-antigen in E. coli, we tested the activ-
ity of the galE mutant variant by introducing the wild type
or mutant version of the mycoplasma galE gene in the
E. coli DH10B strain (mutant for galE), together with the
plasmid pJHCV32 that contains the necessary genes for
the synthesis of the O7 antigen, excepting galE (Valvano
and Crosa, 1989). We observed that both the wild type
and the mutant galE genes are able to complement the
DH10B strain, allowing the expression of the O7 antigen
(Fig. S5), indicating that the activity of the protein product
of the galE gene is not affected in the mutant variant. As
a positive control for O7 antigen expression, we intro-
duced the plasmid pJHCV32 in the E. coli W3110 strain,
which contains an active copy of the galE gene. This
experiment demonstrated that the longer galE encoded in
YCpMmyc1.1-Δglf was functional and is not likely to
cause any phenotype observed for YCpMmyc1.1-Δglf.
Absence of galactofuranose-containing glycans in the
Mmc glf knock-out mutant
The monoclonal antibodyAMMY10, recognising Mmm and
Mmc capsular polysaccharides was tested for its reactivity
with whole cell lysates of Mmc GM12 wild type, Mmc
YCpMmyc1.1 and Mmc YCpMmyc1.1-Δglf (Fig. 3A). As
expected, the antibody reacted with the parental strains
GM12 and YCpMmyc1.1, but not with YCpMmyc1.1-Δglf,
confirming the absence of galactofuranose-containing
galactan in the Δglf mutant. PAS and Coomassie staining
are also shown for comparison: PAS staining (Fig. 3B)
shows the same pattern of staining as the AMMY10 anti-
body staining in the western blot for GM12 and
YCpMmyc1.1. and YCpMmyc1.1-Δglf. The Coomassie
stain is shown as a loading control (Fig. 3C).
Additionally, total carbohydrates from GM12,
YCpMmyc1.1 and YCpMmyc1.1-Δglf were isolated from
both bacteria and culture medium, to include any polysac-
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charides derived from either capsule or EPS. The isolated
carbohydrates were analysed by SDS-PAGE, followed by
western blot analysis employing the AMMY10 antibody,
and by PAS and Coomassie staining (Fig. S6). The
Coomassie staining and dot blot analysis for full-length
recombinant Mmm elongation factor Tu confirmed the
absence of protein in the preparation. Taken together,
the western blot and PAS analyses confirmed that
YCpMmyc1.1-Δglf does not produce a galactofuranose-
containing galactan.
Absence of galactofuranose-containing glycans in the
mutant was also confirmed using immunoelectron micros-
copy (Fig. 4). Polysaccharides recognised by AMMY10
were localised at the cell periphery, on extracellular mate-
rial or in close vicinity to the cells. In the mutant
YCpMmyc1.1-Δglf no binding of the antibody could be
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Fig. 3. YCpMmyc1.1-Δglf lacks the galactofuranose-containing galactan – SDS-PAGE.
Whole bacterial lysates were analysed by SDS-PAGE to an equivalent of 10 μg (A) or 20 μg (B and C) of protein each, either transferred to
nitrocellulose membranes for western analysis using the AMMY10 monoclonal antibody (A) or stained by periodic acid-Schiff stain (PAS) (B)
or Coomassie staining (C). Lane 1: GM12 wild type; Lane 2: YCpMmyc1.1; Lane 3: YCpMmyc1.1-Δglf.
* *
*
*
*
*
0.5 m 0.5 m 
Fig. 4. YCpMmyc1.1-Δglf lacks the galactofuranose-containing galactan – electron microscopy.
Immunoelectron microscopy of M. mycoides using the AMMY10 antibody. Left: GM12; Right: YCpMmyc1.1-Δglf. Antibodies react with the cell
periphery of the wild type (arrowheads) and also some extracellular material (asterisks), while in the mutant no reaction occurred.
60 E. Schieck et al. ■
© 2015 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology, 99, 55–70
detected apart from a few single gold beads (Fig. 4B) that
were also observed in both strains when using only the
secondary antibody (Fig. S7).
Deletion of the glf gene reduces the membrane integrity
of Mmc
Capsular polysaccharides and cell walls contribute to cell
integrity in bacteria. As mycoplasma do not contain a cell
wall, we hypothesised that deletion of CPS content was
likely to compromise membrane integrity of the cell. We
used an assay recently described to screen for bacterial
envelope biogenesis mutants in E. coli (Paradis-Bleau
et al., 2014), based on the assumption that mutants defi-
cient in building blocks/pathways for envelope biogenesis
either lyse more frequently and/or are more permeable to
small hydrophobic molecules. This assay employed
CPRG, a cell membrane impermeable substrate for
β-galactosidase, compared with X-gal, a cell membrane
permeable substrate for β-galactosidase, which provides
a blue/white colony screening system. In our case, lacZ is
under the constitutive spiralin promoter (Lartigue et al.,
2002) in the YCpMmyc1.1 and YCpMmyc1.1-Δglf clones
(Lartigue et al., 2009). To confirm expression of lacZ, the
clones were grown on agar containing either X-gal (cell
membrane permeable) or CPRG. Both clones developed
blue colonies on the X-gal agar, but only YCpMmyc1.1-
Δglf showed hydrolysis of CPRG, indicating that this
strain is more permeable to this compound (Fig. 5). We
concluded that the galactofuranose-containing polysac-
charide contributes to membrane integrity of the myco-
plasma tested, and lack thereof leads to leakiness of the
mycoplasma cell. Another explanation would be that the
enzyme UDP-galactopyranose mutase directly affects
cell membrane integrity if it would be an integral part of
the membrane, but its membrane localisation in the
mycoplasma cell has not been reported yet (Krasteva
et al., 2014).
Evaluation of Mmc glf knock-out mutant generation time
We studied the growth rates of GM12, YCpMmyc1.1 and
YCpMmyc1.1-Δglf. We did not observe a significant dif-
ference between GM12 and YCpMmyc1.1, which exhib-
PPLO agar + X-gal PPLO agar + CPRG
YCpMmyc1.1-Δglf 
YCpMmyc1.1
Fig. 5. Galactofuranose-containing glycans contributes to membrane integrity in Mycoplasma mycoides.
The left panel shows YCpMmyc1.1-Δglf and YCpMmyc1.1, both containing the lacZ gene growing media containing the membrane permeable
β-galactosidase substrate X-gal. As expected colonies show the typical turquoise colouring in both strains. The right panel shows growth on
the membrane impermeable β-galactosidase substrate CPRG (upper right). Only the YCpMmyc1.1-Δglf lacking galactofuranose-containing
glycans show colouring of and around the colonies, whereas the control does not show any colour reactions.
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ited generation times of 56 and 57 min respectively.
However, YCpMmyc1.1-Δglf showed a marked decrease
in growth rate, with a generation time of 89 min, also
indicated by a smaller colony size (Fig. 3). Thus, a
lack of UDP-galactopyranose mutase and therefore of
galactofuranose-containing glycans leads to an increased
generation time and reduced colony size.
Impact of galactofuranose-containing galactan on
cell adhesion
We tested if the galactofuranose-containing glycan plays a
role in adhesion to small ruminant cell line LSM 192
(Zimmermann et al., 2010). Saturation of adhesion was
obtained for wild-type strain GM12 and YCpMmyc1.1 at a
multiplicity of infection (moi) of 1,600 mycoplasma cells per
LSM 192 cell and for YCpMmyc1.1-Δglf at an moi of 25 600
per LSM 192. At this moi, GM12 adhered with an average
of 808 mycoplasmas cells per LSM 192 cell (considered as
wild-type adherence standard = 100%) and its derivative
YCpMmyc1.1 with an average of 178 mycoplasma cells
per LSM 192 cell. The UDP-galactopyranose mutase defi-
cient mutant YCpMmyc1.1-Δglf in contrast showed an
approximately 15-fold higher adhesion compared with the
wild-type strain and 70-fold higher adhesion rate compared
with the isogenic parent YCpMmyc1.1 resulting in 12 486
mycoplasma cells per LSM 192 cell (Fig. 6). The results are
significant (P = 0.0036) according to the non-parametric
Kruskal–Wallis test. We concluded that lack of UDP-
galactopyranose mutase and the galactofuranose-
containing galactan leads to increased adhesion to host
cells.
Effect of galactofuranose-containing galactan on
serum resistance
Evasion of killing by complement is required for colonisa-
tion of many bacterial pathogens. Bacterial polysaccha-
rides, such as capsule and O antigen, have often been
implicated in resistance to complement killing, including
for Mycoplasma spp. (Bolland et al., 2012; Osawa et al.,
2013; Gaurivaud et al., 2014). For this reason, we inves-
tigated if the presence of the galactofuranose-containing
galactan has an effect on serum resistance in Mmc
GM12. Contrary to our predictions, the mutant strain
YCpMmyc1.1-Δglf lacking the galactofuranose-containing
galactan was resistant to serum killing when using fresh
goat serum (Fig. 7) while GM12 and YCpMmyc1.1 were
highly sensitive. All three strains survived treatment with
heat-inactivated serum.
Discussion
Specific protective antibody responses to mycoplasma
proteins have not been identified for diseases caused by
M. mycoides such as CBPP. The chronic phase of CBPP
associated with the presence of viable mycoplasma and
the inability to induce antibodies that neutralise virulence
factors such as l-α-glycerol-3-phosphate oxidase, sug-
gesting the existence of immune evasion mechanisms by
mycoplasma (Mulongo et al., 2013; Schieck et al., 2014).
In this study we investigated the role of polysaccharides of
M. mycoides in the subspecies capri (Mmc), which is phy-
logenetically the closest relative of M. mycoides subsp.
mycoides (Mmm). It has been shown that M. mycoides
produces carbohydrates consisting of galactofuranose
residues, which are either present in the capsule or
excreted into the medium (Bertin et al., 2013; 2015;
Gaurivaud et al., 2014). Our data utilising an anti-
galactofuranose monoclonal antibody confirmed the
presence of this galactan in Mmc GM12 and other
M. mycoides strains (Fig. S2). To gain a better under-
standing on the role of the galactofuranose-containing
galactan in the biology of M. mycoides, we investigated
the glf gene in Mmm and Mmc, predicted to encode UDP-
galactopyranose mutase, the enzyme that converts UDP-
α-D-galactopyranose into UDP-α-D-galactofuranose. We
showed that both subspecies of M. mycoides contain only
one copy of the glf gene that encodes a functional UDP-
galactopyranose mutase. Mmm PG1 and Gladysdale
Fig. 6. Galactofuranose-containing galactan conceals adhesion
molecules in Mycoplasma mycoides.
The histogram displays the results of an adhesion assay of
wild-type GM12 and its derivative mutant strains with primary lamb
cells from carpal joint synovial tissue (LSM 192). Adhesion was
determined using incorporation of [U-14C] palmitic acid in
mycoplasma cells. The adhesion values of the strain GM12 were
used as standard (100%), and the adhesion values of
YCpMmyc1.1 and YCpMmyc1.1-Δglf were compared against that
standard. Standard error is shown.
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harbour two additional but truncated copies of glf, which
do not code for a functional UDP-galactopyranose mutase
(Fig. 2). A frameshift at the same nucleotide position
within the two truncated genes suggests a duplication
event. Whether the encoded truncated proteins are
expressed in vivo and play a different role remains
unknown. Interestingly, proteomic studies have suggested
that the enzyme UDP-galactopyranose mutase is immu-
nogenic in Mmm (Jores et al., 2009), which might be
attributed to a possible high abundance of the protein.
We confirmed the presence of a galactofuranose poly-
saccharide in all Mmm and most Mmc strains tested. Two
out of fifteen Mmc strains did not react with the galactan-
specific antibody. This is in accordance with recently pub-
lished data indicating that members of the Mmc ‘capri’
serovar do not produce galactan (Bertin et al., 2015), as
opposed to the Mmc ‘Large Colony’ serovar (Manso-Silvan
et al., 2009).
Subsequently, we deleted the glf gene in the highly
virulent small ruminant pathogen Mmc GM12 (DaMassa
et al., 1983; 1986) employing the recently developed
genome transplantation technique with editing of the Mmc
genome within yeast as an intermediary host (Lartigue
et al., 2007; 2009). This technique has rendered Mmc a
model organism that can be genetically modified in a way
that has not yet been achieved for other Mycoplasma
species.Additionally, the genome of Mmc contains a single
copy of the gene glf and its gene cluster, which simplifies
mutagenesis approaches and allows unambiguous results
given the known tandem repeats of the glf containing
cluster in Mmm (Fig. 1) (Westberg et al., 2004). As
expected by our KEGG-based in silico analysis, the glf-
deficient strain no longer contains galactofuranose-
containing glycans as shown by immunochemical
experiments involving the murine monoclonal antibody
AMMY10 that recognises M. mycoides galactofuranose
polysaccharides.
Our study provides evidence that UDP-galactopyranose
mutase or more likely its downstream product, the
galactofuranose-containing galactan contribute to mem-
brane integrity, as shown by the β-galactosidase assays
(Fig. 5). The slower growth rate of the glf-mutant strain may
be a result of this ‘leaky membrane’phenotype. We hypoth-
esise that this increased generation time is caused by
disequilibrium of nutrients and salts within the mycoplasma
cell, which leads to the need of more energy-dependent
efforts to maintain basic homeostasis to keep the cell
machinery functioning. Another possibility is that the
reduced growth rate is caused by accumulation of a toxic
intermediate or a structural role of galactofuranose in
modification of glycolipids/glycoproteins. As glycoglyc-
erolipids are key structural membrane elements in Myco-
plasma spp. (Andres et al., 2011), our data indicate that
galactofuranose-containing galactan is a component of
membrane glycoglycerolipids in M. mycoides. Targeting
the galactan in vaccine or antimicrobial development
efforts is a promising avenue to pursue as this is likely to
have an impact on the viability of Mycoplasma spp. in the
host.
Another prominent finding of our study is the lower
adherence of the wild-type strain to carpal joint synovial
cells compared with the glf-deletion mutant. Thus, the
galactofuranose-containing glycans appear to conceal the
adhesion molecules of the wild-type strain, which has also
been described for other pathogens (Feng et al., 2012).
This phenomenon can be interpreted as a kind of trade
105 
104 
103 
102 
101
 GM12 YCpMmyc1.1 YCpMmyc1.1-Δglf
CFU
Fig. 7. Lack of galactofuranose-containing galactan renders GM12 resistant to killing by caprine serum.
Survival of the three strains GM12, YCpMmyc1.1 and YCpMmyc1.1-Δglf after 30 min incubation at 37°C with 50% fresh goat serum is shown.
Serial dilutions from 105-10 cfu were spotted in duplicates, either after incubation with heat-inactivated serum (left on each plate) or with
untreated normal serum (right on each plate).
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off. The galactofuranose polymer covers adhesins that
consequently may be less exposed to the humoral
immune system. Additionally, it is known that M. mycoides
infections are often associated with lower respiratory tract
infections (Thiaucourt and Bolske, 1996; Caswell and
Williams, 2007), and a less adhesive bacterium is likely to
travel deeper into the target region of the lung tissue. This
reduces the likelihood of colonising the upper respiratory
tract (trachea or bronchial tract) and being removed by the
mucocilliary clearance.
Although capsules are reported to be responsible for
resistance to killing by complement in other bacterial
species (Miajlovic and Smith, 2014), the glf deletion
mutant had higher serum resistance compared with its
parental strain. Previous studies looking at Mmm and
M. pulmonis suggest that mycoplasma polysaccharides
protect against complement (Bolland et al., 2012;
Gaurivaud et al., 2014). The study on Mmm investigated
clones of Mmm strain Afadé that either secrete
galactofuranose-containing glycans into the medium or
have a galactofuranose-containing galactan bound to the
cell membrane. The study of Gaurivaud et al. (2014) is
based on Mmm strain Afadé wild-type clones (and not a
galactofuranose negative mutant). Therefore, a compari-
son of their studies with those reported here is difficult.
One possible explanation for our finding is that an impor-
tant trigger for activation of the complement cascade
occurs through galactofuranose residue-binding lectins.
Humans have been reported to possess human intelectin
(hIntL), a lectin that specifically binds to galactofuranose-
containing carbohydrates (Tsuji et al., 2001). Goats have
been reported to encode carbohydrate binding lectin-
encoding genes, but a characterisation of caprine lectins
has not yet been performed (Barik et al., 2014). In the
absence of galactofuranose, the complement system
could function less efficiently due to the absence of
sufficient target molecules for activation. A second possi-
ble explanation is that mycoplasma might express a
complement-degrading factor as reported in other patho-
gens (Rambach et al., 2010), which is more exposed in
the glf mutant. The enhanced exposure of surface myco-
plasma molecules such as lipoproteins (Chambaud et al.,
1999; Browning et al., 2011), glycolipids or glycoproteins
(Jordan et al., 2013), might contribute to protection
against serum killing. Alternatively, the phenotypes
observed in this study, including altered membrane integ-
rity and increased serum resistance and host cell adhe-
sion, could theoretically be correlated to the absence of
the protein UDP-galactopyranose mutase instead of
the galactofuranose-containing glycans. This is rather
unlikely, as UDP-galactopyranose mutase is not part of
the in vitro surface proteome (Krasteva et al., 2014) in
nine closely related Mmm strains tested. It is also possi-
ble that an accumulation of galactopyranose inside the
cell could result in leaky cells; however, that this could
lead to increased adhesion or increased serum killing
resistance is not very likely.
Full genome sequencing of the YCpMmyc1.1-Δglf clone
identified three mutations compared with the parental
strain (not nosidering the genome edits), each of which
could theoretically cause the phenotypes described here.
The deletion of TATA occurring in a region upstream of a
putative lipoprotein (Locus tag: MMCAP2_0900) that
might be involved in phase variable expression, is not
very likely to cause the described growth rate reduction,
decreased membrane integrity, increased adhesion to
host cells or increased serum resistance. A single amino
acid change from threonine to isoleucine in a putative
maltose ABC transporter permease (MMCAP2_0183) is
also not likely to cause the phenotypes described here.
Because the mutated galE gene encodes a functional
UDP-glucose 4-epimerase, it can be excluded as the
cause of the phenotypes observed.
Collectively, our in vitro assays point towards an impor-
tant role of galactofuranose-containing glycans in the
homeostasis of M. mycoides and in the host–pathogen
interactions. We will try to decipher the enzyme pathways
involved in capsule synthesis in the future to identify
targets for vaccine and therapeutic products using syn-
thetic genomics and genome editing techniques as shown
here. Future experiments should involve in vivo studies to
elucidate the role of galactofuranose-containing glycans
in pathogenicity and the potential of this capsule deficient
strain in immunisation experiments.
Experimental procedures
Yeast and Mycoplasma strains used in this study and
culture conditions
Saccharomyces cerevisiae strain W303a containing the
marked Mmc genome YCpMmyc1.1 (Lartigue et al., 2009;
Benders et al., 2010) and its derivative YCpMmyc1.1-Δglf
were grown on synthetic minimal medium containing glucose
(SD) either lacking histidine, or histidine and uracil, or lacking
histidine and supplemented with 1 mg ml−1 5-fluoroorotic acid
(5-FOA, Carl Roth, Germany) (Kouprina and Larionov, 2008;
Noskov et al., 2010).
All Mycoplasma strains Mmc: GM12 wild type,
YCpMmyc1.1, YCpMmyc1.1-Δglf, My325, G1283.94,
G1313.94, 7302, 7730, Kombolcha, 9096.C9415, C260/4,
PG3, CapriL, Y-goat, D2482, Wi18079 and 95010; Mmm:
Afadé, Tan8, Matapi, T1/44, B237, PO2, Madigwan, Fatick,
Shawawa, Astercous, L2, C11, V5 and N6; and Mcc: ATCC
27343 (California Kid) were grown at 37°C in PPLO medium
(Difco, Cat no. 255420) supplemented with 20% heat-
inactivated horse serum (Sigma, Cat. No. H1138), 0.5%
glucose, 0.03% penicillin G, 20 mg ml−1 thallium acetate and
0.9 g l−1 yeast extract, unless otherwise stated, and in SP4
medium with or without 10 μg ml−1 tetracycline as described
elsewhere (Lartigue et al., 2009).
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In silico identification of UDP-galactopyranose mutase
encoding genes (glf) and associated genes in members
of the ‘Mycoplasma mycoides cluster’
The in silico analysis of the galactose pathway in Mycoplasma
mycoides was carried out using the KEGG database
(Kanehisa et al., 2014) (Fig. S1). The genomes of the fully
sequenced ‘M. mycoides cluster’ strains Mmc GM12,
(GenBank accession number CP001621.1), Mmc 95010
(GenBank accession number NC_015431.1), Mmm PG1T
(GenBank accession number NC_005364.2), Mmm Gladys-
dale (GenBank accession number CP002107.1), Mcc
ATCC27343 (GenBank accession number NC_007633.1);
Mccp M1601 (GenBank accession number CM001150.1);
M. leachii 99/014/6 (GenBank accession number
FR668087.1); M. leachii PG50 (GenBank accession number
NC_014751.1) were screened for the gene cluster containing
the predicted UDP-galactopyranose mutase encoding gene
glf using the BLAST algorithms.
Testing the functionality of M. mycoides
UDP-galactopyranose mutase encoded by glf via a
complementation assay in Escherichia coli
Homologues of the gene glf found in Mmc GM12
(MMCAP1_0814, spanning 1,188 bp) and in Mmm Gladys-
dale (MMS_A1075, spanning 1,188 bp and MMS_A1062,
spanning 927 bp) were synthesised using E. coli codon opti-
misation (GenScript), and placed in pUC57 multipurpose
cloning vector; glf candidate genes were subcloned with a
C-terminal His tag in the E. coli expression vector pEXT20
(Dykxhoorn et al., 1996) using EcoRI and HindIII sites. The
synthesised codon optimised nucleotide sequences can be
found in Table S1.
Escherichia coli strain MFF1 (wbbL- glf-) (Feldman et al.,
1999) was complemented with wbbL and pEXT20 containing
the glf homologues under control of the tac promoter.
Only after complementation with a functional UDP-
galactopyranose mutase will synthesis of full-length O antigen
be restored. LPS preparations were done as described previ-
ously (Marolda et al., 2006). Briefly, cultures were diluted to an
optic density of 3.0 per ml (600 nm wavelength), and 1 ml of
each culture was harvested by centrifugation, then resus-
pended in 150 μl of lysis buffer [2% SDS, 4% β-
mercaptoethanol, 10% glycerol, 0.5 M Tris (pH 6.8)], and
incubated at 100°C for 10 min. After addition of 2 μl of protei-
nase K (20 mg ml−1), samples were incubated at 60°C for 2 h.
To this solution was added 150 μl of hot phenol, and samples
were incubated at 70°C for 15 min, followed by 10 min on ice.
After centrifugation, the aqueous phase was mixed with 250 μl
of ethanol and centrifuged, and the precipitated LPS was dried
at room temperature. LPS samples corresponding to an
absorbance of 0.45 at 600 nm were separated by SDS-PAGE,
and LPS silver staining was performed as described else-
where (Tsai and Frasch, 1982).
Ethics statement
All protocols of this study were designed and performed in
strict accordance with the Kenyan legislation for animal
experimentation and were approved by the ILRI animal care
and use committee (reference numbers ILRI2010.06.21 and
ILRI2014.26).
Monoclonal antibody production
Monoclonal antibody AMMY10 was obtained from a fusion of
spleen cells from a mouse immunised against whole, soni-
cated Mmm strain Afadé. The strain was cultured as
described above to a density of 108 colony-forming units
(cfus) ml−1, and centrifuged at 5,000 g for 20 min. The bacte-
ria were suspended in PBS, sonicated three times for 2 min
and mixed with an equal volume of TiterMax Gold (CytRx
Corporation, Georgia, USA). A final amount of antigen
equivalent to 109 mycoplasma cells was injected intraperito-
neally into a 6 month old Balb/C mouse. A booster injection
with the same preparation and amount was given 4 weeks
after the initial immunisation. A final injection was given 6
weeks later, but this time without adjuvant. Four days later the
mouse was sacrificed, and its spleen cells were isolated. A
fusion of the spleen cells with X63.Ag8.653 myeloma cells
was carried out as described previously (Naessens et al.,
1985). The antibodies produced by individual hybridoma cells
were screened using ELISA technique, first for recognition of
whole cell lysates of Mmm Afadé, and then for recognition of
capsular polysaccharides. Hybridoma AMMY10 produced an
IgM antibody that bound to whole mycoplasma and purified
capsular polysaccharide.
Detection of the galactofuranose-containing galactan in
M. mycoides strains
Cultures of 15 Mmc, 1 Mcc and 14 Mmm strains were grown
in PPLO media until log phase. The bacteria were harvested
via centrifugation at 3,000 × g for 30 min and washed with
PBS. Protein concentration was determined using the BCA
Protein Assay Reagent kit (Pierce, Cat. no. 23225), following
manufacturer’s instructions. Samples were blotted onto
Protran BA85 nitrocellulose membrane (Schleicher &
Schuell) at an equivalent of 1 μg total protein per strain, and
let dry at room temperature overnight. The murine monoclo-
nal antibody AMMY10 was incubated with the dot blots at a
dilution of 1:200 at room temperature for 1 h. Following five
washing steps of submerging the membranes in fresh PBS
containing 0.1% Tween20 (PBS-T) for 10 min each, alkaline
phosphatase conjugated α-mouse IgM (dilution 1:30,000,
Sigma, Cat. no. A9688) was added, and the blots were incu-
bated at room temperature for 1 h. After five washes (PBS-T,
10 min each), the blots were stained with NBT/BCIP
(Promega, Cat.no. S380c/S381c) solution and developed at
room temperature for 10–15 min.
Deletion of the glf gene in Mycoplasma mycoides
subsp. capri strain GM12
Saccharomyces cerevisiae W303a harbouring the Mmc
GM12 YCpMmyc1.1 genome (Lartigue et al., 2009; Benders
et al., 2010) was used to generate a glf (MMCAP1_0814)
deletion mutant. The YCpMmyc1.1 genome contains the
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pMycYACTn shuttle vector (Benders et al., 2010), allowing
the stable propagation of the genome in yeast and selection
for tetracycline resistance (tetM) as well as screening for blue
colonies via expression of lacZ in the mycoplasma.
The tandem repeat coupled with endonuclease cleavage
(TREC) constructs to delete glf were generated by PCR
(Noskov et al., 2010). The CORE component of the construct,
containing the endonuclease I-SceI cleavage site, the I-SceI
endonuclease (under the gal1 promoter) and URA3 were
amplified from YCpMmyc1.1-DtypeIIIres::URA3 (Lartigue
et al., 2009) using primers glf CORE-F and glf CORE-R
(Table S2). For the PCR, a mixture of DreamTaq Polymerase
and Pfu proofreading polymerase (Thermo Scientific, Cat
nos. EP0701 and EP0501, respectively) was prepared (1:2.5
vol : vol) in DreamTaq buffer, with an annealing temperature
of 52°C and extension time of 2 min and 20 s. The Tandem
Repeat (TR) part of the deletion construct was amplified from
gDNA isolated from Mmc strain GM12 using primers glf TR-F
and glf TR-R (Table S2) with the PCR conditions used to
amplify the CORE component (see above). The samples
were loaded on a low-melting agarose gel, and gel slices
were excised and kept at −20°C. To fuse the two PCR prod-
ucts (CORE and TR), the gel slices were heated to 65°C, and
about 100 ng of each PCR product was added directly to a
standard PCR reaction mix containing the primers glf
CORE-F and glf TR-R (Table S2). The PCR conditions were:
initial denaturation of 2 min at 94°C, followed by five cycles of
94°C for 1 min, 45°C for 3 min and 72°C for 4 min during
which the complementary ends of the CORE and TR frag-
ments acted as primers to join the sequences. This was
immediately followed by 35 cycles of 94°C for 45 s, 60°C at
45 s and 72°C for 3 min, and a final elongation step of 15 min
at 72°C. The fused PCR products were gel extracted
(QIAGEN, Germany) and subsequently used to transform the
S. cerevisiae strain W303a containing the YCpMmyc1.1
genome, using the LiAc method (Gietz et al., 1992).
Insertion of the construct at the desired locus (i.e. deletion
of glf) was confirmed using primers glf-upstream-seq, glf-
downstream-seq (Table S2), located upstream and down-
stream of gene.
To generate seamless deletions of glf, double stranded
cleavage was induced by plating on galactose containing
medium, followed by 5-FOA (Carl Roth, Germany) counter
selection against the presence of the URA3 gene as
described elsewhere (Noskov et al., 2010). The seamless
deletion was confirmed by sequencing using the up- and
downstream primers described above (Table S2). To verify
that the YCpMmyc1.1 genome was not altered otherwise, an
Mmc-specific multiplex PCR was performed using primers
MPCR1_F – S8G_MPCR8_R (Table S2) and the QIAGEN
Multiplex PCR Kit (QIAGEN, Cat no. 206143).
The completeness of the YCpMmyc1.1-Δglf genome in
yeast was finally confirmed by PFGE. Briefly, yeast agarose
plugs were prepared using the CHEF Mammalian Genomic
DNA Plug Kit (Bio-Rad), following the protocol described
before (Lartigue et al., 2009) and subjected to electrophore-
sis in a 1% pulsed-field agarose gel (Bio-Rad) in 1× TAE, with
a contour-clamped homogeneous electric field (CHEF DR III;
Bio-Rad). Prior to PFGE, yeast chromosomal DNA was
removed from agarose plugs by treating the agarose plugs
with a cocktail of restriction enzymes (AsiSI, FseI and RsrII)
that have multiple recognition sites in yeast chromosomes
and none in Mmc genomes and subsequent electro-removal
of fragmented yeast DNA by agarose electrophoresis. After
that step, the circular DNA that remained in agarose plugs
was BssHII-restricted and finally separated by PFGE. Pulse
times were ramped from 60 to 120 s for 24 h at 6V cm−1. After
electrophoresis, the gel was stained with SYBR Gold, and
PFGE patterns were visualised using a VILBER E-BOX VX5
imager and VisionCapt software.
The intact YCpMmyc1.1-Δglf genome was then trans-
planted into Mcc RE(-) as described before (Lartigue et al.,
2009). The resulting mutant strain Mmc YCpMmyc1.1-Δglf
was confirmed by PCR using the up- and downstream primers,
as well as the Mmc-specific multiplex PCR (Table S2).
PacBio sequencing and genome assembly
High molecular weight DNA from YCpMmyc1.1-Δglf was
sheared in a Covaris g-TUBE (Covaris, Woburn, MA, USA) to
obtain 20 kb fragments. After shearing the DNA size distribu-
tion was checked on a Fragment Analyzer (Advanced Analyti-
cal Technologies, Ames, IA, USA). Six micrograms of the
sheared DNA was used to prepare a SMRTbell library with the
PacBio SMRTbell Template Prep Kit 1 (Pacific Biosciences,
Menlo Park, CA, USA) according to the manufacturer’s rec-
ommendations. The 1.6 μg of the resulting library was size
selected on a BluePippin system (Sage Science, Beverly, MA,
USA) for molecules larger than 10 kb. The recovered library
was sequenced on one SMRT cell with P6/C4 chemistry and
MagBeads on a PacBio RSII system (Pacific Biosciences,
Menlo Park, CA, USA) at 240 min movie length. Sequencing
yielded 62 211 post filter reads corresponding to 863 Mb with
a mean read length of 13 873 bases. Fifty per cent of bases
were in reads longer than 18 050 bases.
For the genome assembly, the PacBio module
‘RS_HGAP_Assembly.2’ in SMRTpipe version v2.3.0 was
used. The seed read length cutoff (reads that after error
correction and trimming are used for Celera assembler) was
set at 21 771 bp. The assembly yielded a contig of 1.104 Mb.
Testing the functionality of the mutated
UDP-glucose-4-epimerase using an E. coli-based
complementation assay
Wild type and mutant galE were synthesised using E. coli
codon optimisation (GenScript) and cloned in the E. coli
expression vector pEXT20 (Dykxhoorn et al., 1996) using
EcoRI and HindIII sites. The synthesised codon optimised
galE nucleotide sequences can be found in Table S1.
LPS was extracted from E. coli whole cells as described
above. Purified LPS was analysed in 12% SDS-PAGE gels
and western blot or silver staining (Fig. S5). For western blot
analysis, a monospecific polyclonal rabbit anti-O7 antigen
(Statens Serum Institut, Denmark) and an IRDye 800CW
goat anti-rabbit (LI-COR Biosciences) were used as primary
and secondary antibodies respectively. Western blots were
visualised using an Odyssey CLx Imager (LI-COR Bio-
sciences). LPS silver staining of SDS-PAGE gels was carried
out as previously described (Tsai and Frasch, 1982).
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Isolation of carbohydrates
Mycoplasma were cultured in 3 l volumes of PPLO media
supplemented with 10% horse serum, 0.5% glucose, 0.03%
penicillin G, 20 mg ml−1 thallium acetate and 0.9 g l−1 yeast
extract until mid-log phase. Total polysaccharides (CPS
and/or EPS) were isolated using slight modification to the
protocols published before (Rurangirwa et al., 1987; Waite
and March, 2002). The pH of the culture was adjusted to pH
5 using glacial acetic acid (Sigma-Aldrich, Cat. no. 100063).
The solution was boiled for 1 h, cooled and filtered through a
Whatman paper (Schleicher & Schuell, 3MM CHR Cat. no.
3030 931). Two volumes of absolute ethanol were added, and
the mixture was stored at 4°C overnight. The precipitate was
collected by centrifugation at 2,600 × g for 15 min, resus-
pended in 200 ml of distilled water and stirred at room tem-
perature for 2 h. After a centrifugation step at 5,000 × g for
30 min, an equal volume of aqueous phenol was added to the
supernatant, and the mixture was incubated at 68°C for 1 h.
Following overnight incubation at 4°C, the mixture was again
centrifuged at 5,000 × g for 30 min, and the phenol extraction
was repeated on the aqueous phase. The aqueous phase
was transferred to a dialysis bag with a molecular weight cut
off 6–8 kDa (Carl Roth, Cat No E666-1) and dialysed against
2 l H2O for 48 h (H2O was exchanged eight times), and the
dialysed material was precipitated using two volumes of
absolute ethanol, kept at 4°C overnight and collected by
centrifugation at 1,000 × g for 30 min. The pellet was resus-
pended in 10 ml distilled H2O and 10 μl of DNAseI (2,000
units ml−1, Pharmacia, Cat. No. 27-0514-01) and 100 μg of
RNAse (Sigma Cat.no. R-4875) was added and incubated at
37°C overnight. SDS was added to a final concentration of
0.5%, followed by addition of 100 μg of proteinase K (BRL
Life Technologies, Cat. no. 25530015), and the mixture was
incubated at 45°C for 24 h. The mixture was transferred to
5 ml of phase lock gel in a 50 ml Falcon tube, one volume of
phenol chloroform was added and mixed thoroughly. After
centrifugation at 5,000 × g for 15 min, the aqueous phase
was transferred to a new tube, and the extraction was
repeated with phenol chloroform isoamylalcohol (25:24:1)
and the aqueous phase was dialysed against 2 l of distilled
water for 4 days (using the same dialysis bags as reported
above, water was exchanged several times daily). Finally, the
carbohydrates were precipitated using 1/10 volume of 3M
sodium acetate and four volumes absolute ethanol, centri-
fuged at 5,000 × g for 30 min, and the pellet was dissolved in
distilled water, followed by a centrifugation at 21 000 × g for
3 min. The supernatant was retained and kept at −20°C until
further experiments. The concentration of carbohydrates was
estimated using the phenol–sulphuric acid method (Masuko
et al., 2005).
SDS-PAGE with Coomassie, PAS staining and
western blot
Twenty micrograms of isolated carbohydrate were analysed
on standard 12% polyacrylamide gels, either stained by
Coomassie or PAS, or transferred to nitrocellulose mem-
branes for western blot analysis. Gels were fixed in Methanol/
Acetic acid/H2O (4/1/5) overnight at room temperature, then
equilibrated in 7% cold acetic acid at 4°C for 1 h, then stained
in 5 gel volumes of 1% periodic acid in 7% cold acetic acid
also for 1 h at 4°C. The gel was subsequently washed with
7% acetic acid at 4°C for 24 h, and the color was developed
using cold Schiff reagent (Sigma, Cat. No. 84655) at 4°C for
1 h.
For western and dot blot analysis, the method described by
Synaptic Systems (Standard protocol for western blots
with alkaline phosphatase staining) (http://www.sysy.com/
protocols/blot.php) was used. Membranes were blocked for
1 h with PBS-T containing 5% skim milk, then incubated for 1 h
with either AMMY10 mAb or rabbit pAb raised against full-
length recombinant Mmm elongation factor Tu (Jores et al.,
2009) (produced by BioGenes GmbH, Germany), diluted
1:200 or 1:10, respectively, in blocking solution. After five
washes (10 min each in PBS-T), the membranes were incu-
bated with alkaline phosphatase conjugated α-mouse IgM
(1:30 000 dilution in blocking solution, Sigma, Cat. No A9688)
or alkaline phosphatase conjugated α-rabbit IgG (dilution
1:5,000, Sigma, Cat. no. A2556) for 1 h, again washed five
times for 10 min in PBS-T. Afterwards, the membranes were
equilibrated with substrate buffer (100 mM Tris-HCl, pH 9.5;
100 mM NaCl; 5 mM MgCl2), developed in BCIP/NBT staining
solution, and the reaction was stopped by washing the mem-
brane in water three times.
Electron microscopy
Cells were fixed in 150 mM HEPES, pH 7.35, containing
1.5% formaldehyde and 1.5% glutaraldehyde. Fixation was
done 30 min at RT and then over night at 4°C. Fixed cell
pellets were immobilised in 4% agar, dehydrated in methanol
and embedded in Lowicryl HM20 (Polysciences, Germany).
After polymerisation by UV-light, ultrathin sections of 25 nm
were immunolabelled at RT as follows: primary antibody,
AMMY10, at 1:100 in PBS containing 0.05% Tween-20 and
5% skim milk powder (blocking buffer) for 3 h; 3 × 5 min PBS
containing 0.05% Tween-20 (washing buffer); secondary anti-
body (goat anti-mouse IgM coupled to 10 nm gold) 1: 50 in
blocking buffer for 1 h; 3 × 5 min in washing buffer; 2 × 2 s in
distilled water. Sections were air dried and then stained 5 min
in 4% uranyl acetate.
Membrane integrity assay
The test was performed as recently described (Paradis-Bleau
et al., 2014) with slight modifications regarding the media
used. GM12, YCpMmyc1.1 and YCpMmyc1.1-Δglf were
plated on PPLO agar plates containing either 20 μg ml−1
5-bromo-4-chloro-3-indolyl β-D-galactopyranoside (X-gal,
Thermo Scientific, Cat. no. R0941) or 20 μg ml−1 Chlorophenol
Red β-D-galactoside (CPRG, Sigma, Cat no. 59767). Color
development was evaluated after 72 h of incubation at 37°C.
Determination of the generation time
The strains GM12, YCpMmyc1.1 and YCpMmyc1.1-Δglf were
grown in standard Mycoplasma broth medium (Mycoplasma
Experience, UK), or on Mycoplasma solid medium containing
0.9% agarose, at 37°C. To determine the generation time in
liquid medium, aliquots were taken every 40 min, diluted by
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successive 10-fold serial dilution steps and spread on solid
medium. The cfus were determined by counting colonies after
4 days of incubation at 37°C with 5% CO2. End-exponential
phase cultures were taken at pH 7.5 when cfu reached
2 × 109 cfu ml−1.
Adhesion to small ruminant cells assay
Adhesion assays were performed using primary lamb cells
from carpal joint synovial tissue (LSM 192) cultivated in
24-well tissue culture plates at 37°C and 5% CO2 to a density
of 6 × 104 cells per well using tissue culture medium (MEM
Biochrom, Berlin, Germany) supplemented with 10% fetal
calf serum, 2.5 mM L-glutamine, 100 U ml−1 penicillin and
100 μg ml−1 streptomycin (Zimmermann et al., 2010).
Mycoplasma strains were grown in 20 ml of standard
Mycoplasma culture medium (Mycoplasma Experience, UK)
containing 2 μCi (74 kBq) of [U-14C] palmitic acid for 3 days at
37°C with 5% CO2. Mycoplasma cultures were harvested by
centrifugation at 9,000 × g for 5 min and were washed three
times in buffer A (0.05 M Tris-HCl, pH 7.2, 0.1 M NaCl and
1 mM CaCl2). Mycoplasma cells were re-suspended in buffer
A and adjusted to a concentration of 109 cfu ml−1.
To determine the saturation of adhesion, 100 μl aliquots of
labelled Mmc suspensions at 104 cfu ml−1 to 109 cfu ml−1 in
bufferAwere added to each well and incubated for 2 h at 37°C.
After removing excess liquid, cells were washed twice with
200 μl of buffer A and subsequently solubilised with 50 μl of
1% (w/v) SDS solution in buffer A for 2 h at 37°C with shaking.
The lysis suspension of each well was then transferred into a
vial, air dried and complemented with 3 ml of scintillation
cocktail containing 5 g l−1 PPO (2,5-Diphenyloxazol from
Merck and Toluol from Fluka). Counts per min were measured
in a Scintillation spectrometer (Perkin-Elmer Liquid Scintilla-
tion AnalyzerTri-Carp 2910 TR). Results are given as mean
values of three independent assays with the corresponding
standard errors. Aliquots of labelled mycoplasma suspension
were measured to determine the incorporation of [U-14C] pal-
mitic acid per cfu Mmc.
The Kruskal–Wallis one-way analysis of variance by ranks
was performed using Prism 6 for MAC OS X Version 6.0e
(GraphPad Software, Inc, La Jolla, CA, USA), as this is a
non-parametric test that can compare more than one sample.
Serum sensitivity assay
Mmc strains GM12, YCpMmyc1.1 and YCpMmyc1.1-Δglf
were cultivated in PPLO media containing 5% horse serum at
37°C overnight and aliquoted before snap freezing and
storage at −80°C. The concentration (cfu ml−1) was deter-
mined. Serum sensitivity was tested as previously described
(Lees-Miller et al., 2013) with minor modifications to adapt for
mycoplasma. Fifty microliters of serial dilutions of myco-
plasma was mixed with 50 μl of fresh caprine serum derived
from a healthy goats (IACUC ref. no. 2014.26) and incubated
at 37°C for 30 min. The added fresh serum was either heat-
inactivated at 56°C for 30 min or neat. Only fresh serum, at
most 3 days old, was used as we observed that storage of
serum at 4°C had a negative effect on the read out of the
assay, i.e. loss of killing activity. Five microliters of each
mixture was spotted in duplicate onto PPLO agar plates and
incubated at 37°C for up to 3 days.
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